Kate Rawson, one of the most insightful and practical observers of the health policy scene in Washington, offers the Coalition for Healthcare Communication her well-informed analysis and a Q&A format.
Anthem Inc. is closely watching for guidance from the U.S. Food and Drug Administration and all available clinical evidence on Biogen Inc.’s Aduhelm to determine the health insurance provider’s coverage policy on the newly approved Alzheimer’s drug.
After collecting billions of dollars in U.S. coronavirus aid, many of the nation’s wealthiest nonprofit hospitals are tapping into disaster relief funds that critics say they do not need.
ISPOR, the professional society for health economics and outcomes research, announced that registration is open for a new webinar that reviews the, “Top 10 Trends in Health Economics and Outcomes Research.”
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and the International Society for Pharmacoepidemiology (ISPE) announced their plans for a one-day conference focused on real-world evidence.
